Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar;9(Suppl 2):S206-S214.
doi: 10.21037/tau.2019.08.36.

Towards a better testicular sperm extraction: novel sperm sorting technologies for non-motile sperm extracted by microdissection TESE

Affiliations
Review

Towards a better testicular sperm extraction: novel sperm sorting technologies for non-motile sperm extracted by microdissection TESE

Cathy L Mangum et al. Transl Androl Urol. 2020 Mar.

Abstract

Non-obstructive azoospermia (NOA) is the most severe form of male factor infertility. It is characterized by a lack of spermatogenesis in the seminiferous tubules. Microdissection testicular sperm extraction (microTESE) has significantly improved testicular sperm retrieval rates compared to conventional techniques for NOA. Following testicular biopsy, the sperm is usually non-motile and contained within seminiferous tubules requiring extensive laboratory processing to find individual sperm sufficient for artificial reproductive technologies (ART). Current techniques include mechanical and enzymatic processing which is time-consuming and often damaging to sperm. We review novel techniques that may help improve sperm retrieval rates after microTESE including microfluidics (dielectrophoretic cell sorting, spiral channel sorting, and pinched flow fractionation), fluorescence-activated cell sorting (FACS), and magnetic-activated cell sorting (MACS).

Keywords: Microfluidics; azoospermia/therapy; intracytoplasmic/methods; male; microdissection/methods; sperm injections; sperm retrieval; sperm separation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The focused issue “Contemporary Issues and Controversies in Men’s Health” was commissioned by the editorial office without any funding or sponsorship. JMH serves as an unpaid editorial board member of Translational Andrology and Urology from Aug 2019 to Jul 2021. R Samuel: Nanonc—equity stake; wFluidX Inc.—equity stake. TG Jenkins: Nanonc (microfluidic sperm sorting company, inherent biosciences—leadership position/founder. KI Aston: Nanonc—equity stake. BK Gale: Nanonc—equity stake. JM Hotaling: Boston Scientific, Endo Pharmaceuticals—research and fellowship grant; Nanonc, StreamDx, Andro360, inherent biosciences—leadership position/founder. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Illustrations of microfluidics devices for non-motile cell sorting.

Similar articles

Cited by

References

    1. Agarwal A, Mulgund A, Hamada A, et al. A unique view on male infertility around the globe. Reprod Biol Endocrinol 2015;13:37. 10.1186/s12958-015-0032-1 - DOI - PMC - PubMed
    1. Ghuman N, Ramalingam M. Male infertility. Obstet Gynaecol Reprod Med 2018;28:7-14. 10.1016/j.ogrm.2017.10.007 - DOI
    1. Esteves SC. Clinical management of infertile men with nonobstructive azoospermia. Asian J Androl 2015;17:459-70. - PMC - PubMed
    1. Silber SJ. Microsurgical TESE and the distribution of spermatogenesis in non-obstructive azoospermia. Hum Reprod 2000;15:2278-84. 10.1093/humrep/15.11.2278 - DOI - PubMed
    1. Craft I, Tsirigotis M, Bennett V, et al. Percutaneous epididymal sperm aspiration and intracytoplasmic sperm injection in the management of infertility due to obstructive azoospermia. Fertil Steril 1995;63:1038-42. 10.1016/S0015-0282(16)57544-X - DOI - PubMed